| Valproic acid | Approved Investigational | ASXL3 | 80816 |
downregulated | Valproic Acid results in decreased expression of ASXL3 mRNA | 18q12.1 | |
| Valproic acid | Approved Investigational | ASXL3 | 80816 |
upregulated | Valproic Acid results in increased expression of ASXL3 mRNA | 18q12.1 | |
| Valproic acid | Approved Investigational | ATAD1 | 84896 |
downregulated | Valproic Acid results in decreased expression of ATAD1 mRNA | 10q23.31 | |
| Valproic acid | Approved Investigational | ATAD2 | 29028 |
downregulated | Valproic Acid results in decreased expression of ATAD2 mRNA | 8q24.13 | |
| Valproic acid | Approved Investigational | ATAD2B | 54454 |
downregulated | Valproic Acid results in decreased expression of ATAD2B mRNA | 2p24.1-p23.3 | |
| Valproic acid | Approved Investigational | ATAD3A | 55210 |
upregulated | Valproic Acid results in increased expression of ATAD3A mRNA | 1p36.33 | |
| Valproic acid | Approved Investigational | ATAD5 | 79915 |
downregulated | Valproic Acid results in decreased expression of ATAD5 mRNA | 17q11.2 | |
| Valproic acid | Approved Investigational | ATAT1 | 79969 |
downregulated | Valproic Acid results in decreased expression of ATAT1 mRNA | 6p21.33 | |
| Valproic acid | Approved Investigational | ATCAY | 85300 |
upregulated | Valproic Acid results in increased expression of ATCAY mRNA | 19p13.3 | |
| Valproic acid | Approved Investigational | ATF1 | 466 |
downregulated | Valproic Acid results in decreased expression of ATF1 mRNA | 12q13.12 | |
| Valproic acid | Approved Investigational | ATF2 | 1386 |
downregulated | Valproic Acid results in decreased expression of ATF2 mRNA | 2q31.1 | |
| Valproic acid | Approved Investigational | ATF3 | 467 |
upregulated | Valproic Acid results in increased expression of ATF3 mRNA | 1q32.3 | |
| Valproic acid | Approved Investigational | ATF5 | 22809 |
downregulated | Valproic Acid results in decreased expression of ATF5 mRNA | 19q13.33 | |
| Valproic acid | Approved Investigational | ATF6 | 22926 |
downregulated | Valproic Acid results in decreased expression of ATF6 mRNA | 1q23.3 | |
| Valproic acid | Approved Investigational | ATF7 | 11016 |
downregulated | Valproic Acid results in decreased expression of ATF7 mRNA | 12q13.13 | |
| Valproic acid | Approved Investigational | ATF7 | 11016 |
upregulated | Valproic Acid results in increased expression of ATF7 mRNA | 12q13.13 | |
| Valproic acid | Approved Investigational | ATF7IP | 55729 |
downregulated | Valproic Acid results in decreased expression of ATF7IP mRNA | 12p13.1 | |
| Valproic acid | Approved Investigational | ATF7IP2 | 80063 |
upregulated | Valproic Acid results in increased expression of ATF7IP2 mRNA | 16p13.2-p13.13 | |
| Valproic acid | Approved Investigational | ATG10 | 83734 |
upregulated | Valproic Acid results in increased expression of ATG10 mRNA | 5q14.1-q14.2 | |
| Valproic acid | Approved Investigational | ATG101 | 60673 |
upregulated | Valproic Acid results in increased expression of ATG101 mRNA | 12q13.13 | |
| Valproic acid | Approved Investigational | ATG14 | 22863 |
downregulated | Valproic Acid results in decreased expression of ATG14 mRNA | 14q22.3 | |
| Valproic acid | Approved Investigational | ATG3 | 64422 |
upregulated | Valproic Acid results in increased expression of ATG3 mRNA | 3q13.2 | |
| Valproic acid | Approved Investigational | ATG4A | 115201 |
upregulated | Valproic Acid results in increased expression of ATG4A mRNA | Xq22.3 | |
| Valproic acid | Approved Investigational | ATG5 | 9474 |
downregulated | Valproic Acid results in decreased expression of ATG5 mRNA | 6q21 | |
| Valproic acid | Approved Investigational | ATG5 | 9474 |
upregulated | Valproic Acid results in increased expression of ATG5 mRNA | 6q21 | |